Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Younghee Kim

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Signal Transduction and Targeted Therapy|April 14, 2021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degenerationSiddharth Narendran, Felipe Pereira, Praveen Yerramothu, et al.
Science (New York, N.Y.)|November 22, 2014
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activityBenjamin J Fowler, Bradley D Gelfand, Younghee Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2020
Chronic Dicer1 deficiency promotes atrophic and neovascular outer retinal pathologies in miceCharles B Wright, Hironori Uehara, Younghee Kim, et al.
Nature Medicine|December 5, 2014
IL-18 is not therapeutic for neovascular age-related macular degenerationYoshio Hirano, Tetsuhiro Yasuma, Takeshi Mizutani, et al.
Signal Transduction and Targeted Therapy|March 1, 2016
Intravenous immune globulin suppresses angiogenesis in mice and humansReo Yasuma, Valeria Cicatiello, Takeshi Mizutani, et al.
Cell|May 1, 2012
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88Valeria Tarallo, Yoshio Hirano, Bradley D Gelfand, et al.
Signal Transduction and Targeted Therapy|February 27, 2016
Human IgG1 antibodies suppress angiogenesis in a target-independent mannerSasha Bogdanovich, Younghee Kim, Takeshi Mizutani, et al.
Nature Medicine|November 28, 2017
cGAS drives noncanonical-inflammasome activation in age-related macular degenerationNagaraj Kerur, Shinichi Fukuda, Daipayan Banerjee, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Signal Transduction and Targeted Therapy|April 14, 2021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degenerationSiddharth Narendran, Felipe Pereira, Praveen Yerramothu, et al.
Science (New York, N.Y.)|November 22, 2014
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activityBenjamin J Fowler, Bradley D Gelfand, Younghee Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2020
Chronic Dicer1 deficiency promotes atrophic and neovascular outer retinal pathologies in miceCharles B Wright, Hironori Uehara, Younghee Kim, et al.
Nature Medicine|December 5, 2014
IL-18 is not therapeutic for neovascular age-related macular degenerationYoshio Hirano, Tetsuhiro Yasuma, Takeshi Mizutani, et al.
Signal Transduction and Targeted Therapy|March 1, 2016
Intravenous immune globulin suppresses angiogenesis in mice and humansReo Yasuma, Valeria Cicatiello, Takeshi Mizutani, et al.
Cell|May 1, 2012
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88Valeria Tarallo, Yoshio Hirano, Bradley D Gelfand, et al.
Signal Transduction and Targeted Therapy|February 27, 2016
Human IgG1 antibodies suppress angiogenesis in a target-independent mannerSasha Bogdanovich, Younghee Kim, Takeshi Mizutani, et al.
Nature Medicine|November 28, 2017
cGAS drives noncanonical-inflammasome activation in age-related macular degenerationNagaraj Kerur, Shinichi Fukuda, Daipayan Banerjee, et al.
Pageof 12